readthroughSign in
CompanyPRTANasdaqDublin 2, L2

Prothena Corp Public Ltd Co

Prothena develops therapeutic antibodies and protein-based treatments for neurodegenerative and amyloid diseases.

SCHEDULE 13G/ANov 13Latest SEC filing
Nov 12Latest story